medical statistics

epidemiologic study methods

probability
%
% , - . / $ #0

)*

$ 1 *

% * . 3 4'

5-0 ! *

"

; 9 * $ 0 . #5

3 #?

; . #5

&'

5-0 !

6 $ $ 5- 9 * $ # 05

*(
5-0 (

comparison *#
' #B # 0

5-

@@

"

0 *
2

AC

# E$ 0

5- :C

:C

"

0@

:AC !
$ 5

#
*

% A :!2

D@ : #

H 0

,
G

C#

GK

<# $ 0

$
* $

# L #0

D ?G . #
A

$ 8

62

A* :C $ !2
#0

confounding @

:C <# -*
I2

:0@ 6 2

0@ D#
%,

% 4 2 . G 1#

A*F0 #2 G 3

% 62

A +
:C

uses and abuses

$ 5A

7 !)

@ 0 +

<#

62

>* (

data

0@ D#

"#

standards of health

6 # - * 0 *: 8

hypothesis

% "#

*2 +
#2

=<

$ 0

&3

$ # 5G +

0 $

0 $
#0

2 +
J 0 .#

62
%
%

@@

'#

5-0 data

0 *D

MN #

%
O !2

!*

+H 0 0

+
!

O7 5 *
O:

K0 -

5-0

(
*#

(
!2

J #
P

NP 5 # <#P A

)*

*2

* descriptive s.
6#

G0

!2

R 0

% <#A

:B2

62

62

inferential s.
Q3 $

#@

* $ A
!

testing
=

"

3S '

SN * $

= systematic error
$ Q

#0

9 " :C 7 # *

3 S# 0

$ 5 $G D
A* 6 @

9 " 7 *2

% :! - # L : A* F@

<B

; bias
"

#@0 Q -

3 H

6 * N *H

F@ ; information

*6 *

ED

2 $5

5-

>*

;6 * N * +
N *+D

confounding K *
<

#0 0 K

0@ H 0/ :C N * $
= declassifications 7 *2

N * +

!A*

%% !2

selection= $

G$ 5

G@

! *Q -

+1

# $

" !+G
A G

:CP -

P 0" DP * 7

C# #@
-

'#

= perkson,s ;

#@

A N * :C ##5

6* =

D * :C Q - H

<

% $3

*5 <# @

; P 0 A <# -

5-0 A 5

0 A #

$0

0 *0 N * +

K* 0 G #@
0N *
# 5G

#?

* $5 %D @

:C !- F@ non response bias

G A# N

N * +

A N* :C A 0

#0

'

#@ # 5FC > 3 4 *
% !*

0 * M B#
P-

$02
$0

2 C$ N

$ 0 2 C$ N

" > 35 J #

#50

%$ N $ <
$ $

6@

D0

" *

A*G . G S$
:P C #P C 5 2 #C 6 @

7 -5 9

<# B M "

6 @ G :C :! 9

#?

C2
< N0

0 ? lead- time : !# $ N N * +
* UF@ V N

0 * J B * F@ G#
#2 *

5-0 V N
#

:C N *

* $5

D0 0

*Q -

* H

"P *

P !N

D0

" #53

= 7 *2

N * $ M * 3 $
$ NP

#C <# " :C 7

=N *;
3

:C J #

;6 * N *

:C ! -

% P"

=$

5-/

! - 6@ G

$ 5 $G <#A
& '& (

- J 0 %
$

60

<#A

:C

survival

recall #53
% <# @

# L

%
9 "

N *+
J #

0 P

# P

CD 2 # G

J #

0 *#

>3 5K

$5

B*

$/

interviewer bias
5#

#W

N *+

L* # L

%
P

P C 0 ?#

<# P @

0 F0 #W

!G

2 "*

J #

"6@

" unacceptability bias

. I

>

P ":

<

# L

A"

#)*

; matching

,C5 :
0

Srestriction *

% =#
<#P A

; 0 2

#
P-

<#A

#
#CG

#?
$

BL 6

+(

0 *0

#S

B2

, -

%<
% A *5

#
*

:C

# L

AC

J #

$0

0@ :C A '

chance error

% *

#L2

validity

&

'!

B $ #)* J L0 0
K G$

H 0 $/ K* 0 F@

G9#
#0

# L

0 reducing bias

stratification

accuracy

N *+
#53 ;

%
N

$#
% 2

G :P B

5 C2

F@

. /
J #

$0

" !

A 50
&

reliability
#

#0

#?

! *$

$G 9 "

"2

0 &
2

A
:0
C
D3 5 :0

B
D3 5 :0
D
:
:0

2
!

sensitivity
A
.
A+C

:C ' #

#0
specificity

7 -5 V
$

.
D
B+D
8
X

:C ' #

* 8

#0

KC

$ 5 :
3 &

positive predictive value

.

A
A+B

Q* # 0

* J # 0:

Q* # 0

#0

&/

D2
-

* J #

- $G

negative predictive value

D
C+D

$ :

&/
- $G
4

accuracy
.

A+D
A+B+C+D

0 *

prevalence 5
.

A+C
A+B+C+D

0 *$ 0 2

M
'

statistical analysis
6&

variables
=$
$
$0 ?

$ #5
A

<# N

04

$N

Y *>
#@

= "#/ $ :!A*

<#

&

N ? <# #

A C;

"#B

% ' 0

6#

(
7

measures of dispersion
%& P

MN $ <#5C :@

K*5 @ 0

: 0 # +
A C;

= "#/ $

# 5G . N5#

"

#-*9

#L2 G #05G $ 0 7

range V
% = :@

; . N5#

"
%

confidence interval
:C
2

0@

$5

#0

Q3

!*

B % <#A

3 D

=CI

95 8 ;

% " 9

* <

:
'

H 0 9 B* # #5
5

3 8

*0 @

:@

=&

<

standard deviation . #
$G :* &# L2 $ 5 3 7 # * :
% :@

0 #"

K*5 :@
C &# 05 $ 5 3 =

7 # *
*

; :@

7 # *
+ :0 #
$

7 # *

&0 ? $5 7

B #-

.#

;
)

5-0 +

0 #"

variance
% # 5G . #

7 # * : 0# #3

standard error :
% *

: 0# #3

&

F@

.#

7 # *

measures of central tendency , ( & 5 (

%
D # 1

:0

:C

%
= skewed ; !

MN

"#

0 #F

:C @

K!

/ "#

G
2 ;:

" $ # 5G

5-0

"

0 #F

KN

D # 1

<##5

" # 5G

"

K!

mode )

5
1#

(D

median

V 2

= N* G
%

@ 0 KN

V 2

"#/

mean

= outlier ;

-3

D *

1)

KN

&# * K !
correlation 9 +

1
& &

correlation coefficient
(

Z$ T #
= !# $ @#

= 0"

6 -* #@

= pearson @ 0 # ; $ # L $ 0 @ 0 #

"G

<#- 0

$#

;$# L

$0 0

= 6 53 V
> *

3 K "J B * $ # L

$
$ 0 00

;$# L

"

"

GD

"

GD

$0 "
C

0H

*$ <

N5 # 9 *

! * $ :B* G 5I

' #B # 0

!2

%<

# L

: ;&
< =

' 0H 0 4

"K
$0

X
X

hypothesis testing
$[ % A*P

< "9

* $G

@* "

H 0 7

>*

* @ C C2

null hypothesis @ H0 ? >

CP2

D0P 0 P AC

F@ H

3G <# @

A5 A -

0 *

<#A

$ 0 :!2

#C

K*G

H 0 $ K* 0 F@
% *

< +

chance error
#L2

5 C2

alternate hypothesis @ Ha ? '

F@ D0 0 9

= <# @

0 *;

$ 0 :!2

< =

# B $G

% @ C C2
" !
%

2 $ 5
% !@

-B

0#

<

* H0 ' #B J C# @ alpha ?

$ 5
C

= p- value ; p

* H0 ' #B
V#

$G

0" @ beta ?

& " !
& " !+

power of test # 0

level of significances

&

< " $[

&AB C

&

P "# P
CP2

=8

D0P 0 9 P

=
P

$
:P

"G ; p 0.05 $
7

C2

F@ D0 0

2 * <#

' #B J C#

D0 0 # #

00

GV

H0 ' #B J C#

* 9 B*

3 ; Ha
6@

# 9

' #B J C# K C $5

0 D ? H0

H0 J C#P 7 5

H0J C# 7 5
%K

"

0 $5 :' # C

! #0

H0 ' #B

*#
0

3 p=5% ;

p>5% 3 9 5

$ <# #' 0 #0

!2

C> 3

# L
A* #0

x
A* #0

:C

y
"# $ 5 $ "# $ 0

A C@ 0

0 &

$ "# $ 0 "

@ 0G ratio

! 0 * proportion @

?%
100\

J #

" 9 B* :C

%$5

:C &

@ 0 $ 5 $ N <

J # 0 $02

x ; 1000 \

:C

#L

1
x
x+y
& 1

rate

A* #0 # #

"G

0 #@

= <#A

y
%=$ N <
P

:C H

:C $ N $

0 *D

'#

$ <

<# C

M P " 0P * population at risk #@

<#A

0 * 7

incidence rate 5
G9 #

J # 0 02

#@

% <# @
9 P * $P <#A

-B G

M "

attack rate

%
<
=

<# C :C = <

G;$ N $ <
= 2 C; <

* N <# C :C 9

point prevalence

#-*

% = @ * #-*

%J #

$'#

#$ K

$
@ *:

&3D

& 1

* N <# B 0"#
&1

% #@

<#A

& 1
&

#-*
0

#-0

9 ": J #

period prevalence E =
; :* > 30

&*
&1

prevalence rate

#-*

P5 # P- *
3

! 0 *0 K* #0

;<

@ * :C 9

'

<
:C $

'#

1
prospective study
retrospective study or case A
control
cross sectional 5
experimental study , R C T, s

;D

$3
/& F &

3
% 3

P* @
; P

# &'

V#

= 0

G J #P
B2

:C H

3 ;

$3

J 00 $ 5# -

<
3 <#A

* N <# B 9 * $

;D

AC 0

M "

<# @

J #

0 =M "
%

<# 05 <#A
P

1
M P"

C#
C

N *

02

0P * P C#

B5

" >A

$5

; &0 * !- J # ] V #
# ? G #'

$ N :C H

<N5#

:C %

# $
C

concurrent

# 0 *#

"G <#A

:C $

$ 5

$*

F@ $ 5

" 0 <# @

$ 5 " = : 5 $ #- J # G
% :'

$ N :C A

MN

$5

02 " *@# 6 -* #@

5 @#C

CJ 0 2
!

risk measures
;D

<

+ relative risk
$

$0 "

!
A

# :C

/
2
#!

B
75
D
625
B + D 700

A + C 300
8

X = absolute risk

$0M "

0 *

C
X
= @ #@ ; $ *
#? $0 M "
C+D
$ J # M " 0 * = 2 B* 5-0 ; 9 0 4
9' &

0 *

#@

;$*

A + BW
8
<# @

0 * *

X
$ $

% J #
8

A/(A+B)
C/(C+D)

^ &0 * &#@ $G $ *

X <# @

:C M "

0 *X @

<# @

:C M "

0 *

#? $

A*

0 0 #05 $ *

!
> 35

+?

$ 0 F-*

02 " *@# M " 0 *

% &!2

9 P

$ 0 P2

P $ 3P

0 *
P-

3 D0 0 $ 0 2

0 *

3 73

09 * $

$0M "

0 * + #@

$'#

attributable risk

& &

# K* < B
-

$0M "

#G

4 ($ # &&
$5

0 * X Q N $5

#@

#@
'#
AR = A / ( A+ B ) C/ ( C + D ) = 225 - 75 = 0.065
300
700

$ 8

$ 5

#P - 0

5P -0 Q N $5

Q NP $P 5

#@

:C 35
'#

$3 $0 =$

0 *$ 5

* #@

! 0 *0 Q N $5
; <# @

"

$'#

#0 6 0

F@

$ #0

<

$ 0 !# $ @# H

5F

"# 3

:C

3 #@

number needed to treat NNT *3;$ % 3

#

<# C

<

02 $

" K

retrospective study case- control A

$02

-G #

N5# C $
$

"G &

= medical records ; 0@
$07

0@ D0 0 :0 * #@
#

- ;J #

B5 "G
GM "

"G

:C 2

$3

-F0 A *#
A

J #

$ M * 3 :C $

3A0 0 2

0 *#

" &5 A

:C-

:C

$ M * 3 :C $5
# 0 *#

0
$ M * 3

$*

:C N *

&' G *

% <# * J # /
#

<#
0

D -* #@

*# " :C-

$
:

$0 "

-"*

5 !*

&

# $/
* = 7 *2

#
F@ ;

1
A
40

B
20

& 1

C
20

D
30

:C = " 0 ; :0 * #@

6 * N

$A

* $

6 * $G

3 B

0 *# #

@ * *5

0 * ; <# * J # /
0

3X
# 5G 7 ' G

odd ratio
GM "

* D L0 J B * M "

5 :C :0 * #@

<#

#@

0#

6 @ G D L0 &!2
#

$5

A D
X
BC
Q A 0 * odd ratio
*

* $ * $G 2

7&

# G

E 7!

2
&

<G#

9&

$0$ #

*5 $A

J #0

/&
#

0 *
#0

0"#
#/ 0 *
* 35
#

^ 0 * $G

* @ S

C#

=<

G;.

= 7 B2 ; : CG

*2

5-

0" J #

#
#/

ratio
B-

:0 * #@

:C <N5#

# *

& *

SM "

& *

J #

!-

#05G

B5 "G

B5
"G

"

& * "G
&

72

*
#

#CG

5A

&

$/ = M " 9

$ M *

5G 5-0

;M -

" 9 B*0 @0 #

% = M - <# C ; $ N $
survey 4

#0

S 00

"

D @

"G

0 *9

"

0 2

#0

N *

/& F &

$_ H

<# @
=M -

#0

:C <-

C*

= &0 * ; B5 # ? N *

##

$0V

D#

<

K *

.3 6

0@

K #G

. G :C # # ?

BL 6

=$ < &

% 3

J #

H 0 $
N * F@

'#

# F # A)[ 7 A0 A N
# L

5-

02

*@#

G A

H 0
# L $

&

AC @

@
#0

S 0!? S <

&' G *
6&
# L :

0
E& &

# L

5$ 5
* *

independent variable '/ &

# L

7 A

:C N *

&# 5 6 * N * 7
; dependent <

S$

cross over
<# C 0

3
.G # #

. &# 5 $
95 $ N $ <

G polls M # "

&

# :
&

double- blind clinical trial

J #

'#

@ * ; * N @ * :C $

experimental or randomized study E

KC J #

$5 <

% A 5-G
#@

I
J #

<# C

<# #' 0 5I

@ *

B5

cross- sectional
$

$5

02

# 5G

9 "

:C <N5#

#L2 G
5 A

#@

$ 5 "

:C
6&
# L :

$0 "

Q - $G $5

<# @

J #

C#

confounding v *

'!

# L

#I

# L

! *@

<

6&

H;D

3[ = @

# L ;

/ $

<# *

:!2
@

5 > A

#0

$ @# 6 -* #@ :

C# # A)F0 4
# L

<# *

$5

$ @#

0 $

#
&* G :

$0 "
$

N Q# 0 . 3

6 *G # F 4'
$
% 0#

<# *

# . G :C Q

5 $ *

# L 5

$ @#

" D

&0 ?

$50

# L
0

7&

>A

5 > A
<

*5

# :C

$0:
5 @ 0 5-0